The overexpression of m6A regulators has been implicated in tumorigenesis in lung cancer, breast cancer, and certain gynecological tumors, yet conflicting roles of m6A regulators persist in other cancer types [6,7,15]. The gene discussed is METTL3; the disease is lung carcinoma.